Kevin M. Brown, Dmd, Pc | |
9 Pleasant St Ayer MA 01432-1329 | |
(978) 772-3747 | |
Not Available |
Full Name | Kevin M. Brown, Dmd, Pc |
---|---|
Speciality | Dentist - General Practice |
Location | 9 Pleasant St, Ayer, Massachusetts |
Authorized Official Name and Position | Kevin M Brown (PRESIDENT) |
Authorized Official Contact | 9787723747 |
Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
Mailing Address | Practice Location Address |
---|---|
Kevin M. Brown, Dmd, Pc 9 Pleasant St Ayer MA 01432-1329 Ph: (978) 772-3747 | Kevin M. Brown, Dmd, Pc 9 Pleasant St Ayer MA 01432-1329 Ph: (978) 772-3747 |
NPI Number | 1780705889 |
---|---|
Provider Enumeration Date | 04/03/2007 |
Last Update Date | 08/22/2020 |
Identifier | Type | State | Issuer |
---|---|---|---|
1780705889 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
1223G0001X | Dentist - General Practice | 17176 (Massachusetts) | Primary |
News Archive
Affecting almost 600,000 people worldwide every year, and with only a 50% survival rate, oral squamous cell carcinoma (OSCC) is one of the more common and deadly forms of cancer.
Adherence to a Mediterranean diet, an eating plan filled with fruits and vegetables, legumes, cereals, bread, fish, fruit, nuts and extra-virgin olive oil, may be associated with the severity of the skin condition psoriasis.
Regenerative medicine is a cross-disciplinary field that aims to repair or replace abnormal organs by growing tissues in the laboratory or cells for therapy.
Caris Life Sciences, a leading biosciences company focused on fulfilling the promise of personalized medicine in oncology, has signed a distribution agreement with IPS Genomix to facilitate patient access to its tumour profiling service, Molecular Intelligence, in select Middle Eastern and African markets.
Cancer diagnostics company Biomoda, Inc. today announced in its new monthly President's Column, posted at www.biomoda.com, that it is extending the pilot clinical trial of its CyPath diagnostic assay for the detection of early-stage lung cancer to recruit additional participants for the positive control group, patients who have been diagnosed with lung cancer but have not yet begun treatment for the disease.
› Verified 4 days ago